Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Summary

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Timeline

Start

2020-02-10

Primary completion

2020-10-02

Completion

2021-02-26

Drugs

Indications